Absorb bioresorbable vascular scaffold vs. everolimus ‐eluting metallic stent in small vessel disease: A propensity matched analysis of COMPARE II, RAI, and MAASSTAD‐ABSORB studies

ConclusionIn this propensity‐matched analysis pooling SVD patients of three large prospective studies, incidence of composite device‐related events was comparable between BVS and EES up to 2 years follow‐up. However, higher rates of stent thrombosis were found in the BVS group.

Source: Catheterization and Cardiovascular Interventions - March 7, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Giuseppe Tarantini, Giulia Masiero, Alberto Barioli, Valeria Paradies, Georgios Vlachojannis, Paola Tellaroli, Bernardo Cortese, Gaetano di Palma, Attilio Varricchio, Alfonso Ielasi, Bruno Loi, Giuseppe Steffenino, Daisuke Ueshima, Marco Mojoli, Pieter Sm Tags: Coronary Artery Disease Source Type: research